Molecules at Play in Cancer
"Molecules at Play in Cancer" is a collection of 24 research articles on recent findings about some important molecules responsible for either cancer development and proliferation, or anti-cancer therapy. It covers a wide range of tissues and organs affected by cancer: adrenal glands, bloo...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_100114 | ||
| 005 | 20230511 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230511s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7302-1 | ||
| 020 | |a 9783036573038 | ||
| 020 | |a 9783036573021 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7302-1 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PS |2 bicssc | |
| 100 | 1 | |a Iacobas, Dumitru |4 edt | |
| 700 | 1 | |a Iacobas, Dumitru |4 oth | |
| 245 | 1 | 0 | |a Molecules at Play in Cancer |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (366 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a "Molecules at Play in Cancer" is a collection of 24 research articles on recent findings about some important molecules responsible for either cancer development and proliferation, or anti-cancer therapy. It covers a wide range of tissues and organs affected by cancer: adrenal glands, blood, breasts, muscles, ovaries, prostate, stomach, and testicles. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Research & information: general |2 bicssc | |
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 653 | |a Agkistrodon | ||
| 653 | |a leucine | ||
| 653 | |a membrane | ||
| 653 | |a phenylalanine | ||
| 653 | |a venom peptides | ||
| 653 | |a familial hyperaldosteronism type 3 | ||
| 653 | |a KCNJ5 | ||
| 653 | |a adrenal tumor | ||
| 653 | |a β-catenin | ||
| 653 | |a MALDI-IMS | ||
| 653 | |a CYP11B2 | ||
| 653 | |a PNU-74654 | ||
| 653 | |a TNF receptor-1 | ||
| 653 | |a apoptosis | ||
| 653 | |a testicular cancer | ||
| 653 | |a alveolar epithelial stem cells | ||
| 653 | |a ACE2 | ||
| 653 | |a SARS-CoV-2 | ||
| 653 | |a COVID-19 | ||
| 653 | |a RBD of spike glycoprotein | ||
| 653 | |a metastatic microenvironment | ||
| 653 | |a ovarian cancer | ||
| 653 | |a exosomal microRNA | ||
| 653 | |a biomarker | ||
| 653 | |a early diagnosis | ||
| 653 | |a BSG | ||
| 653 | |a basigin | ||
| 653 | |a CD147 | ||
| 653 | |a MM | ||
| 653 | |a multiple myeloma | ||
| 653 | |a survival | ||
| 653 | |a AP5M1 | ||
| 653 | |a BAIAP2L1 | ||
| 653 | |a CRISPR | ||
| 653 | |a ENTPD2 | ||
| 653 | |a master regulator | ||
| 653 | |a LOC145474 | ||
| 653 | |a MTOR | ||
| 653 | |a PRRG1 | ||
| 653 | |a VIM | ||
| 653 | |a WFDC3 | ||
| 653 | |a circulating tumor cells | ||
| 653 | |a non-small-cell lung cancer | ||
| 653 | |a single cell next generation sequencing | ||
| 653 | |a nematode | ||
| 653 | |a microenvironment | ||
| 653 | |a cancer | ||
| 653 | |a research | ||
| 653 | |a ZEB2 | ||
| 653 | |a prognosis | ||
| 653 | |a immune cells | ||
| 653 | |a cyclin D1 | ||
| 653 | |a epidermal growth factor receptor (EGFR) | ||
| 653 | |a stage I gastric cancer | ||
| 653 | |a early gastric cancer | ||
| 653 | |a node-negative gastric cancer | ||
| 653 | |a B-cell maturation antigen (BCMA) | ||
| 653 | |a soluble BCMA (sBCMA) | ||
| 653 | |a multiple myeloma (MM) | ||
| 653 | |a anti-BCMA CAR-T cell therapy | ||
| 653 | |a INDEL | ||
| 653 | |a genetic ancestry | ||
| 653 | |a Amazon | ||
| 653 | |a biomarkers | ||
| 653 | |a KIRC | ||
| 653 | |a GOT2 | ||
| 653 | |a multi-omics | ||
| 653 | |a epigenetics | ||
| 653 | |a immune cell infiltration | ||
| 653 | |a arsenic trioxide | ||
| 653 | |a Parkin | ||
| 653 | |a HeLa | ||
| 653 | |a autophagy | ||
| 653 | |a salivaomics | ||
| 653 | |a breast cancer | ||
| 653 | |a saliva | ||
| 653 | |a molecular biological subtype | ||
| 653 | |a HER2 status | ||
| 653 | |a estrogen receptors | ||
| 653 | |a progesterone receptors | ||
| 653 | |a HPV DNA in breast | ||
| 653 | |a nested PCR | ||
| 653 | |a gastric cancer | ||
| 653 | |a hsa-miR-942-3p | ||
| 653 | |a AR | ||
| 653 | |a MAPK/ERK signaling pathway | ||
| 653 | |a HCC | ||
| 653 | |a CTCs | ||
| 653 | |a miRNAs | ||
| 653 | |a proteomics | ||
| 653 | |a fenbendazole | ||
| 653 | |a microtubule polymerization | ||
| 653 | |a self-administration | ||
| 653 | |a EMT | ||
| 653 | |a UQCRB | ||
| 653 | |a ROS | ||
| 653 | |a hypoxia | ||
| 653 | |a HIF-1α | ||
| 653 | |a deuterium-depleted water (DDW) | ||
| 653 | |a deuterium-depleted yolk (DDyolk) | ||
| 653 | |a anticancer drug development | ||
| 653 | |a D/H ratio | ||
| 653 | |a production of metabolic water | ||
| 653 | |a ketogenic diet | ||
| 653 | |a NEAT1 | ||
| 653 | |a liver cancer cell line | ||
| 653 | |a drug resistance | ||
| 653 | |a SOD2 | ||
| 653 | |a MAPK | ||
| 653 | |a AKT | ||
| 653 | |a rhabdomyosarcoma | ||
| 653 | |a sarcoma | ||
| 653 | |a mouse model | ||
| 653 | |a Nf1 | ||
| 653 | |a Ink4a/Arf | ||
| 653 | |a vincristine | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7207 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/100114 |7 0 |z DOAB: description of the publication |